Study of Biostate for Treatment of Children With Hemophilia A Complicated by Antibody Development

Summary

This is a clinical study to investigate how well Biostate works in treatment of male patients below the age of 12 years who have a clotting factor deficiency that is aggravated by the development of antibodies. The antibodies are directed against the clotting factor that is given for replacement therapy and usually make therapy unsuccessful. The treatment used in this study is called immune tolerance therapy.

Timeline

Start

2012-12

Primary completion

2013-12

Completion

2013-12

Drugs

Indications